Invo Fertility vs Anbio Biotechnology
Anbio Biotechnology is the larger business, with $8.6m of revenue in fiscal 2025 against $6.8m for Invo Fertility (1.3 times as much). Anbio Biotechnology grew faster (5.6% against 4.7%). Anbio Biotechnology kept more of each dollar of sales as profit: a net margin of 74.1% against -340.9%. Anbio Biotechnology carries less debt relative to equity (0.0% against 28.0%).
| Latest fiscal year | Invo FertilityIVF, 2025 | Anbio BiotechnologyNNNN, 2025 |
|---|---|---|
| Revenue | $6.8m | $8.6m |
| Revenue growth | 4.7% | 5.6% |
| Net income | −$23.3m | $6.4m |
| Operating margin | -105.8% | 66.7% |
| Net margin | -340.9% | 74.1% |
| Return on equity | — | 27.0% |
| Free cash flow | −$7.1m | — |
| Cash | — | $7.8m |
| Total debt | $2.0m | $0 |
| Debt to equity | 28.0% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | — |
| Market value | $4.3m | $158m |
| Price vs our value range | — | — |
| Moat score | 34 (Weak) | — |
| Insider trades, 12 months | 0 buys, 1 sales | 0 buys, 0 sales |